Healthcare
February 13, 2018 / 7:17 AM / 10 months ago

BRIEF-Diurnal Says European Commission Granted Paediatric Use Marketing Authorisation For Alkindi

1 Min Read

Feb 13 (Reuters) - Diurnal Group Plc:

* EUROPEAN COMMISSION HAS GRANTED A PAEDIATRIC USE MARKETING AUTHORISATION FOR ALKINDI

* ANTICIPATE FIRST LAUNCH OF ALKINDI IN Q2 2018 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.